Search research articles
Contact Us
Filters
Showing results (71-80 of 87) with videos related to
Page
of 9
Sort By:
Free Radical Research
|
December 3, 2008
Comparison of rat liver and brain proteasomes for oxidative stress-induced inactivation: Influence of ageing and dietary restriction
Kalavathi Dasuri, Anhthao Nguyen, Le Zhang, et al.
Depression and Anxiety
|
May 10, 2022
The effects of varenicline, bupropion, nicotine patch, and placebo on smoking cessation among smokers with major depression: A randomized clinical trial
Paul M Cinciripini, George Kypriotakis, Charles Green, et al.
The American Journal on Addictions
|
March 29, 2022
Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center
Jason D Robinson, Maher Karam-Hage, George Kypriotakis, et al.
The American Journal of Psychiatry
|
December 11, 2024
Effects of Varenicline, Bupropion, Nicotine Patch, and Placebo on Treating Smoking Among Persons With Current or Past Major Depressive Disorder: Secondary Analysis of a Double-Blind, Randomized, Placebo-Controlled Trial
George Kypriotakis, Paul M Cinciripini, Charles E Green, et al.
Psycho-Oncology
|
June 11, 2015
Grasping the 'teachable moment': time since diagnosis, symptom burden and health behaviors in breast, colorectal and prostate cancer survivors
Shirley M Bluethmann, Karen Basen-Engquist, Sally W Vernon, et al.
Journal of Affective Disorders
|
February 17, 2009
Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination
Rachel E Maddux, Lawrence P Riso, Daniel N Klein, et al.
Journal of Clinical Psychopharmacology
|
December 13, 2017
Improvement of Smoking Abstinence Rates With Increased Varenicline Dosage: A Propensity Score-Matched Analysis
Maher Karam-Hage, George Kypriotakis, Jason D Robinson, et al.
JAMA
|
May 2, 2024
Smoking Cessation After Initial Treatment Failure With Varenicline or Nicotine Replacement: A Randomized Clinical Trial
Paul M Cinciripini, Charles E Green, Sanjay Shete, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
November 8, 2023
Examining the Association between Abstinence from Smoking and Healthcare Costs among Patients with Cancer
George Kypriotakis, Seokhun Kim, Maher Karam-Hage, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|
July 1, 2021
Reporting Treatment Fidelity in Behavioral Tobacco Treatment Clinical Trials: Scoping Review and Measurement Recommendations
Ramzi G Salloum, Alana M Rojewski, Megan E Piper, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 87) with videos related to
Sort By:
Page
of 9
Free Radical Research
|
December 3, 2008
Comparison of rat liver and brain proteasomes for oxidative stress-induced inactivation: Influence of ageing and dietary restriction
Kalavathi Dasuri, Anhthao Nguyen, Le Zhang, et al.
Depression and Anxiety
|
May 10, 2022
The effects of varenicline, bupropion, nicotine patch, and placebo on smoking cessation among smokers with major depression: A randomized clinical trial
Paul M Cinciripini, George Kypriotakis, Charles Green, et al.
The American Journal on Addictions
|
March 29, 2022
Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center
Jason D Robinson, Maher Karam-Hage, George Kypriotakis, et al.
The American Journal of Psychiatry
|
December 11, 2024
Effects of Varenicline, Bupropion, Nicotine Patch, and Placebo on Treating Smoking Among Persons With Current or Past Major Depressive Disorder: Secondary Analysis of a Double-Blind, Randomized, Placebo-Controlled Trial
George Kypriotakis, Paul M Cinciripini, Charles E Green, et al.
Psycho-Oncology
|
June 11, 2015
Grasping the 'teachable moment': time since diagnosis, symptom burden and health behaviors in breast, colorectal and prostate cancer survivors
Shirley M Bluethmann, Karen Basen-Engquist, Sally W Vernon, et al.
Journal of Affective Disorders
|
February 17, 2009
Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination
Rachel E Maddux, Lawrence P Riso, Daniel N Klein, et al.
Journal of Clinical Psychopharmacology
|
December 13, 2017
Improvement of Smoking Abstinence Rates With Increased Varenicline Dosage: A Propensity Score-Matched Analysis
Maher Karam-Hage, George Kypriotakis, Jason D Robinson, et al.
JAMA
|
May 2, 2024
Smoking Cessation After Initial Treatment Failure With Varenicline or Nicotine Replacement: A Randomized Clinical Trial
Paul M Cinciripini, Charles E Green, Sanjay Shete, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
November 8, 2023
Examining the Association between Abstinence from Smoking and Healthcare Costs among Patients with Cancer
George Kypriotakis, Seokhun Kim, Maher Karam-Hage, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|
July 1, 2021
Reporting Treatment Fidelity in Behavioral Tobacco Treatment Clinical Trials: Scoping Review and Measurement Recommendations
Ramzi G Salloum, Alana M Rojewski, Megan E Piper, et al.
Page
of 9